Annual report pursuant to Section 13 and 15(d)

Statements of Cash Flows

v3.23.1
Statements of Cash Flows - USD ($)
 5 Months Ended 12 Months Ended
Dec. 31, 2021
Dec. 31, 2022
Cash Flows From Operating Activities:    
Net loss $ (92,078) $ (564,499)
Adjustments to reconcile net loss to net cash used in operating activities:    
Profit interest compensation   549,854
Income from investments held in the Trust Account 0 (3,399,497)
Changes in operating assets and liabilities:    
Prepaid expenses (35) (187,013)
Prepaid Consulting Services   (434,868)
Accounts payable and accrued expenses   258,920
Accrued formation cost 5,975 0
Franchise taxes payable 0 200,000
Income tax payable   707,005
Other long-term liabilities 0 1,380,500
Net Cash Used In Operating Activities (86,138) (1,489,598)
Cash Flows From Investing Activities:    
Cash deposited into Trust Account   (235,750,000)
Net Cash Used In Investing Activities   (235,750,000)
Cash Flows From Financing Activities:    
Proceeds from issuance of Class B common stock to Sponsor 25,000  
Sale of Units in the Initial Public Offering, net of underwriting discount   225,400,000
Sale of Private Placement Warrants to the Sponsor   13,100,000
Proceeds from Sponsor promissory note 86,000 0
Repayment of the Sponsor promissory note   (86,000)
Proceeds from related party advances 75,576 38,500
Repayment of related party advances   (152,128)
Payment of offering costs, net of reimbursements (98,418) (9,841)
Net Cash Provided By Financing Activities 88,158 238,290,531
Net change in cash 2,020 1,050,933
Cash at beginning of period 0 2,020
Cash at end of period 2,020 1,052,953
Supplemental disclosure of non-cash financing activities:    
Deferred underwriters' compensation charged to temporary equity in connection with the Public Offering   6,900,000
Operating costs paid by related party on behalf of the Company 25,750 12,302
Non-cash financing activities:    
Deferred offering costs included in accrued offering costs $ 305,000 $ 0